Evidence map›Paper›PMID 40473417›Full record

Trial reportBMJ mental health2025

Early Start Denver Model effectiveness in young autistic children: a large multicentric randomised controlled trial in two European countries.

Marie-Maude Geoffray, Marie-Joelle Oreve, Lucie Jurek, Sandrine Sonie, Carmen Schroder, Veronique Delvenne, Sabine Manificat, Sandrine Touzet, Jay Agathe, Flavia Mengarelli and 13 more

Registry-linked trialAbstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in BMJ mental health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02608333 (Impact of Early Intervention on the Global Development of Children With Autism Spectrum Disorder in a European French-speaking Population Dr Marie-Maude GEOFFRAY Le Vinatier Hospital), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02608333 nacompletednot on this map

Impact of Early Intervention on the Global Development of Children With Autism Spectrum Disorder in a European French-speaking Population Dr Marie-Maude GEOFFRAY Le Vinatier Hospital

TypeinterventionalSponsorHôpital le VinatierRan2015 to 2021Enrolled180ConditionsAutism Spectrum DisorderArmsESDM-12, control group
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Marie-Maude GeoffrayCH Le Vinatier, Bron, Auvergne-Rhône-Alpes, France Marie-maude.geoffray-cassar@ch-le-vinatier.fr.ORCID 0000-0002-5528-3613
Marie-Joelle OreveService universitaire de psychiatrie de l'enfant et de l'adolescent, CH Versailles, Le Chesnay, Île-de-France, France.ORCID 0000-0003-3354-1025
Lucie JurekCH Le Vinatier, Bron, Auvergne-Rhône-Alpes, France.ORCID 0000-0001-7568-568X
Sandrine SonieCentre de ressources autisme Rhône-Alpes, CH Le Vinatier, Bron, Auvergne-Rhône-Alpes, France.ORCID 0000-0003-2694-6307
Carmen SchroderDepartment for Child and Adolescent Psychiatry, CHU de Strasbourg, Strasbourg, Grand Est, France.ORCID 0000-0001-7264-2086
Veronique DelvenneChild and adolescent psychiatry, HUDERF, Brussels, Belgium.ORCID 0000-0001-6644-3208
Sabine ManificatCH Le Vinatier, Bron, Auvergne-Rhône-Alpes, France.
Sandrine TouzetCH Le Vinatier, Bron, Auvergne-Rhône-Alpes, France.ORCID 0000-0002-0354-7920
Jay AgatheCH Le Vinatier, Bron, Auvergne-Rhône-Alpes, France.ORCID 0000-0002-8343-5426
Flavia MengarelliCH Le Vinatier, Bron, Auvergne-Rhône-Alpes, France.ORCID 0009-0009-2265-7218
Gallifet NatachaCH Le Vinatier, Bron, Auvergne-Rhône-Alpes, France.ORCID 0009-0002-0444-295X
Nicolas PetitCH Le Vinatier, Bron, Auvergne-Rhône-Alpes, France.ORCID 0000-0002-9910-2706
Mario SperanzaPublic Health, Paris-Saclay University, Versailles, France.ORCID 0000-0002-1785-5764
Stéphane BahramiVersailles Saint-Quentin-en-Yvelines University Faculty of Medicine, Montigny-le-Bretonneux, France.ORCID 0009-0003-2546-950X
Laetitia BouveretCHU Lyon, Lyon, Auvergne-Rhône-Alpes, France.ORCID 0009-0002-7339-3119
Sara Linda DochezCH Le Vinatier, Bron, Auvergne-Rhône-Alpes, France.ORCID 0009-0004-5365-4080
Pauline AuphanCH Le Vinatier, Bron, Auvergne-Rhône-Alpes, France.ORCID 0009-0002-7548-3484
Amelie ZelmarCHU Lyon, Lyon, Auvergne-Rhône-Alpes, France.ORCID 0009-0000-2937-2711
Bruno FalissardUniversité Paris-Saclay, Gif-sur-Yvette, Île-de-France, France.ORCID 0000-0002-2418-4954
Sophie CarlierHopital Universitaire de Bruxelles, Laeken, Bruxelles, Belgium.
Mikail NourredineCHU Lyon, Lyon, Auvergne-Rhône-Alpes, France.ORCID 0000-0002-0952-0091
Angélique DenisService Biostatistiques, CHU Lyon, Lyon, Auvergne-Rhône-Alpes, France.ORCID 0000-0003-4117-1714
Olivia Febvey-CombesCHU Lyon, Lyon, Auvergne-Rhône-Alpes, France.ORCID 0000-0002-4888-0815

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEvidence regarding early interventions based on the Naturalistic Developmental Behavioral Interventions framework, such as the Early Start Denver Model (ESDM), suggests efficacy for autistic children. However, the effectiveness of ESDM across diverse cultural contexts remains under-researched.

objectiveTo assess the effectiveness of ESDM compared with treatment as usual (TAU) on overall development in young children with autism spectrum disorder (ASD).

methodThis parallel, randomised controlled trial, using a modified Zelen design, was conducted in five Child and Adolescent Mental Health Services in France and Belgium. A total of 180 children aged 19-36 months, who met autism criteria and were referred by community professionals, were randomly assigned to either receive 12-hour weekly ESDM+TAU or TAU alone. The primary outcome was the change in developmental quotient (DQ) on the Mullen Scale of Early Learning, assessed blindly from baseline to 24 months post randomisation.

findingsFrom September 2015 to March 2019, 180 children were randomly assigned to either ESDM+TAU (n=61, girls=21.7%) or TAU alone (n=119, girls=15.4%). Three children dropped out immediately after randomisation. Compared with TAU alone, children in the ESDM+TAU group did not significantly improve global DQ (endpoint mean difference 3.82 (95% CI -1.25 to 8.89), p=0.14). CONCLUSIONS AND CLINICAL IMPLICATIONS: Our findings suggest that ESDM+TAU cannot be universally recommended for young children with ASD. Further research is required to evaluate the long-term effectiveness of ESDM and identify subgroups that may benefit more, thereby guiding optimal implementation strategies. TRIAL REGISTRATION NUMBER: NCT02608333.

Indexed as

Autism Spectrum DisorderBehavior TherapyEarly Intervention, EducationalBelgiumChild, PreschoolFemaleFranceHumansInfantMaleChild & adolescent psychiatry

Identifiers

PMID40473417
PMCPMC12142086

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.